What potential risk reduction could be achieved with evolocumab treatment? A simulation based on observational data from a cohort of users in 10 European countries - Sorbonne Université Access content directly
Conference Papers Year : 2020
No file

Dates and versions

hal-03970175 , version 1 (02-02-2023)

Identifiers

  • HAL Id : hal-03970175 , version 1

Cite

K Ray K, I Bridges, E Bruckert, B van Hout, M Sibartie, et al.. What potential risk reduction could be achieved with evolocumab treatment? A simulation based on observational data from a cohort of users in 10 European countries. European-Society-of-Cardiology (ESC) Congress, Aug 2020, Amsterdam, Netherlands. ⟨hal-03970175⟩
3 View
0 Download

Share

Gmail Facebook X LinkedIn More